Anti-CD40 antibody induces antitumor and antimetastatic effects: The role of NK cells

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 89-94

  Turner, J G ^a   Rakhmilevich, A L ^a   Burdelya, L ^a   Neal, Z ^a   Imboden, M ^a   Sondel, P M ^a   Yu, H ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD 40 ANTIBODY; CD40 ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DRUG EFFECT; DRUG MECHANISM; KNOCKOUT MOUSE; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR;

EID: 0035159078     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.89     Document Type: Article

References (31)

1. + T-helper and a T-killer cell
2. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
3. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
4. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154
5. Cutting edge: Dendritic cells require maturation via CD40 to generate protective antitumor immunity
6. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge
7. Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7
8. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
9. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
10. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
11. Role of natural killer cells in cancer
12. Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy
13. The role of natural killer cells in immune surveillance of cancer
14. Mice deficient of the CD40 ligand
15. Antibody-IL-12 fusion proteins are effective in SCID mouse models of prostate and colon carcinoma metastases
16. The SCID but not the RAG-2 gene product is required for 5μ-Sε heavy chain class switching
17. Injection of cDNA encoding interleukin-12 results in inhibition of tumor establishment at a distant site in a murine renal carcinoma model
18. Gene therapy with dominant negative STAT3 induces apoptosis and suppresses growth of the murine melanoma B16 tumor in vivo
19. Accurate identification of experimental pulmonary metastases
20. Induction of Ly-6A/E expression by murine lymphocytes after in vivo immunization is strictly dependent upon the action of lFN-αβ and/or lFN-γ
21. Human tumour antigens recognized by T cells: New perspectives for anti-cancer vaccines?
22. Cells and cytokines in immunotherapy and gene therapy of cancer
23. Natural killer cells and cancer
24. + T cells from mice bearing large tumors
25. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma
26. A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
27. Triggering of murine NK cells by CD40 and CD86 (B7-2)
28. -/- dendritic cells tO provide tumor protection is rescued by CD40 ligation
29. Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand
30. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis
31. Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand